Long-term prescription of α-blockers decrease the risk of recurrent urolithiasis needed for surgical intervention-a nationwide population-based study.

Long-term prescription of α-blockers decrease the risk of recurrent urolithiasis needed for surgical intervention-a nationwide population-based study.

Show other versions (1)

PURPOSE:α1 receptors and subtypes have been confirmed to distribute in human pelvis and calyces recently. As used in ureteral stones, α-blocker treatment may facilitate kidney stone passage and long-term prescription of α-blocker may decrease the risk of recurrent urolithiasis. The aim of this study...

Full description

Bibliographic Details
Main Authors: Chia-Chu Liu, Hui-Min Hsieh, Chia-Fang Wu, Tusty-Jiuan Hsieh, Shu-Pin Huang, Yii-Her Chou, Chun-Nung Huang, Wen-Jeng Wu, Ming-Tsang Wu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395263?pdf=render

Similar Items

Similar Items